Ladone Mary Kay
SEC Form 4 insider trading activity
Ladone Mary Kay has filed 5 SEC Form 4 filings (6 transaction rows) across 4 companies, including KMTS, INGN, BVS, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 11, 2026.
On the most recent filing, Ladone Mary Kay is listed as Director at KESTRA MEDICAL TECHNOLOGIES, LTD. Inside the rolling window, Ladone Mary Kay reported no open-market purchases and 1 open-market sale totaling $98K in KMTS.
Companies traded
Other insiders at KMTS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$98K
reported sales (SEC code S)
Companies
4
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ladone Mary Kay made?
Ladone Mary Kay has filed 5 SEC Form 4 filings (6 transaction rows) across 4 companies, including KMTS, INGN, BVS since 2025.
Which companies does Ladone Mary Kay trade?
Ladone Mary Kay has filed SEC Form 4 disclosures for 4 companies, including KMTS, INGN, BVS.
When was Ladone Mary Kay's most recent SEC Form 4 filing?
Ladone Mary Kay's most recent SEC Form 4 filing on Tracefour is dated Sep 11, 2026.
What is Ladone Mary Kay's total buy and sell value in the current window?
Inside the rolling retention window, Ladone Mary Kay bought $0 and sold $98K based on SEC Form 4 filings.
What was Ladone Mary Kay's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,908 KMTS shares on 2026-09-08, worth $98K, per SEC Form 4 filings.